Endurant Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-96,444
| Closed | -$6.53M | – | 32 |
|
|
2023
Q3 | $6.53M | Buy |
96,444
+35,636
| +59% | +$2.41M | 5.87% | 4 |
|
|
2023
Q2 | $4.35M | Sell |
60,808
-36,449
| -37% | -$2.61M | 3.8% | 6 |
|
|
2023
Q1 | $6.75M | Sell |
97,257
-44,163
| -31% | -$3.07M | 3.47% | 8 |
|
|
2022
Q4 | $9.59M | Buy |
141,420
+40,372
| +40% | +$2.74M | 3.89% | 8 |
|
|
2022
Q3 | $5.54M | Buy |
+101,048
| New | +$5.54M | 1.8% | 20 |
|
|
2022
Q2 | – | Sell |
-240,271
| Closed | -$15.9M | – | 52 |
|
|
2022
Q1 | $15.9M | Sell |
240,271
-84,457
| -26% | -$5.6M | 4.2% | 4 |
|
|
2021
Q4 | $18.9M | Buy |
+324,728
| New | +$18.9M | 4.57% | 4 |
|
|
2021
Q2 | – | Sell |
-238,099
| Closed | -$11.8M | – | 62 |
|
|
2021
Q1 | $11.8M | Buy |
238,099
+181,208
| +319% | +$9.01M | 3.09% | 8 |
|
|
2020
Q4 | $2.84M | Buy |
+56,891
| New | +$2.84M | 1.03% | 33 |
|
|
2019
Q4 | – | Sell |
-31,031
| Closed | -$1.38M | – | 54 |
|
|
2019
Q3 | $1.38M | Sell |
31,031
-93,828
| -75% | -$4.18M | 0.5% | 34 |
|
|
2019
Q2 | $5.15M | Buy |
+124,859
| New | +$5.15M | 2.03% | 23 |
|